Agomelatine-Induced Maculopapular Rash: A Case Report
Journal Title: Noropsikiyatri Arsivi - Year 2013, Vol 50, Issue 4
Abstract
Agomelatine is a new antidepressant with a unique pharmacological profile, which includes the melatonergic agonistic (MT1 and MT2 receptors) and 5-HT(2C) antagonistic properties (1). Due to this mode of action, agomelatine is typically well tolerated and remarkably free from adverse side-effects at therapeutic dosages. The most common adverse effects reported with agomelatine use were headache, nasopharyngitis, and gastrointestinal complaints. Rarely skin rashes are reported during the treatment with agomelatine (1, 2). We also report a case of a 32-year-old woman with major depressive disorder (MDD) who has been treated with agomelatine and developed maculopapular rashes most prominent on the trunk.
Authors and Affiliations
Aslıhan OKAN İBİLOĞLU, Lut TAMAM
Keywords
Related Articles
- EP ID EP104568
- DOI 10.4274/npa.y6514
- Views 99
- Downloads 0
Şizofreni Hastalarına Bakım Verenlerin Duygu İfadelerini Belirlemede Camberwell Aile Görüşmesi ile Duygu İfadesi Ölçeğinin Karşılaştırılması
Giriş: Araştırmanın amacı, şizofreni hastalarına bakım verenlerin duygu ifade düzeylerini belirlemede Camberwell Aile Görüşmesi (CAG) ve Duygu İfadesi Ölçeğini (DİÖ) karşılaştırmaktır. Yöntem: Araştırmanın örneklemin...
Klozapin Tedavisini Pimozid ile Güçlendirme Yaklaşımı: Tedaviye Dirençli Bir Şizofreni Olgusu
Tedaviye dirençli şizofreni hastalarında monoterapide tercih edilen klozapin tedavisine % 40-70 oranında yeterli yanıt alınamamaktadır. Bu yüksek oranlarda bildirilen tedavi yanıtsızlığı klinisyenleri klozapini diğer far...
Reliability and Validity of the Turkish Version of the Health Anxiety Inventory
Introduction: Health anxiety is seen in the clinical presentation of both somatoform disorders, especially hypochondriasis and anxiety disorders. In this study, we aimed to perform the reliability and validity analyses...
Agomelatine-Induced Maculopapular Rash: A Case Report
Agomelatine is a new antidepressant with a unique pharmacological profile, which includes the melatonergic agonistic (MT1 and MT2 receptors) and 5-HT(2C) antagonistic properties (1). Due to this mode of action, agomelati...
Evaluation the Cognitive Functions in Parkinson’s Disease Patients with<br /> Neuropsychometric Tests and to Identify its Clinical Correlates
Objective: In this study, we aimed to evaluate the cognitive functions in Parkinson’s disease patients with using neuropsychological assessment and to identify its clinical correlates in Parkinson’s disease. Methods: Th...